Alkahest
Redwood City, US · Founded 2014 · 34 employees on LinkedIn
Find your way into Alkahest
Sign up to see every warm intro you have to Alkahest
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alkahest team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alkahest uses proteomics data and advanced computational methods to understand disease mechanisms, identify drug targets, and discover biomarkers for therapeutic development, with a focus on aging-related diseases like Parkinson's and Alzheimer's.
Founders & leadership
Alkahest was founded in 2014 by Anton Wyss-Coray and Karoly Nikolich.
AW
Anton Wyss-CorayCo-founder
KN
Karoly NikolichCo-founder
TK
Tamara KentExecutive
SL

Scott LohrSenior Vice President, InformaticsScott Lohr is Senior Vice President of Informatics at Alkahest, a company using proteomics and computational methods to identify drug targets and biomarkers for aging-related diseases. He has worked across biotech companies in roles involving software development and target identification.
BL
Benoit LehallierSenior Director, Data Science
MF
Mia FengAssociate Director, Biostatistics
IK
Idit KostiAssociate Director, Real World Data Analytics
NW
Nathan Watson-HaighAssociate Director, Genome Informatics
MB
Michael BechaufAssociate Director, Software and Data Engineering
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2014
▶$3.5MraisedAug 2014 · 3 investors · BiotechnologyRule 506(b)
▶$3.5MraisedAug 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anton Wyss-CorayDirector
- Tamara KentExecutive Officer
- Karoly NikolichExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- Minimum investment
- $300K
- Proceeds to insiders
- $324K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Alkahest do?
- Alkahest uses proteomics data and advanced computational methods to understand disease mechanisms, identify drug targets, and discover biomarkers for therapeutic development, with a focus on aging-related diseases like Parkinson's and Alzheimer's.
- Who founded Alkahest?
- Alkahest was founded by Anton Wyss-Coray, Karoly Nikolich in 2014.
- How much funding has Alkahest raised?
- Alkahest has disclosed $3.5M raised across 1 round.
- Where is Alkahest headquartered?
- Alkahest is headquartered in Redwood City, US.
